已收盘 12-19 16:00:00 美东时间
+0.270
+1.26%
Surrozen (NASDAQ:SRZN) reported quarterly losses of $(8.36) per share which missed the analyst consensus estimate of $(1.14) by 636.56 percent. This is a 1800 percent decrease over losses of $(0.44) per share from the
11-08 05:09
The latest announcement is out from Surrozen ( ($SRZN) ). On October 14, 2025, ...
10-18 04:27
On October 14, 2025, Surrozen, Inc. (the "Company") received notice from TCGFB, Inc. ("TCGFB") that TCGFB has elected to terminate the Collaboration Agreement (the "Collaboration Agreement") between TCGFB and the
10-18 04:25
Surrozen, a biotech company focusing on治疗严重眼病的靶向疗法,于9月2日向四位新员工授予总计45,710股的股票期权。这些期权的行权价为每股12.32美元,归属期为4年,分月归属。此举措符合纳斯达克上市规则,并需员工持续服务至各归属日期。选项已由公司薪酬委员会批准,作为吸引新员工加入的激励措施。
09-04 20:15
The latest update is out from Surrozen ( ($SRZN) ). On August 29, 2025, Surroze...
08-30 05:15
Surrozen press release (NASDAQ:SRZN): Q2 GAAP EPS of $2.55. Net: Other income, net was $16.2 million, compared to $3.7 million for the same period in 2024. The variance is primarily attributable to a ...
08-12 03:12
Surrozen, Inc. ( ($SRZN) ) has released its Q2 earnings. Here is a breakdown of...
08-09 12:18
Surrozen (NASDAQ:SRZN) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $(1.11) by 329.73 percent. This is a 131.91 percent increase over losses of $(7.99) per share from the
08-09 04:09